Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence and predictors of arthralgia after initiation of vedolizumab in patients with inflammatory bowel disease: a retrospective cohort study.
Kokkotis G, Zampeli E, Tzouvala M, Giotis I, Orfanos P, Benetou V, Stoupaki M, Leontidis N, Leonidakis G, Kitsou V, Gaki A, Lagiou P, Michopoulos S, Bamias G. Kokkotis G, et al. Among authors: michopoulos s. Eur J Gastroenterol Hepatol. 2023 Apr 1;35(4):371-375. doi: 10.1097/MEG.0000000000002527. Epub 2023 Feb 13. Eur J Gastroenterol Hepatol. 2023. PMID: 36827531
Technetium-99m labelled red blood cells scintigraphy and not iminodiacetic acid cholescintigraphy facilitates the discrimination of hepatic cirrhosis from fibrosis.
Papantoniou V, Valsamaki P, Skorda L, Papantoniou I, Delichas Z, Zacharakis G, Michopoulos S, Dimopoulos M, Koskinas I. Papantoniou V, et al. Among authors: michopoulos s. Hell J Nucl Med. 2015 Sep-Dec;18(3):238-42. doi: 10.1967/s002449910306. Epub 2015 Nov 18. Hell J Nucl Med. 2015. PMID: 26574694
Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.
Karmiris K, Avgerinos A, Tavernaraki A, Zeglinas C, Karatzas P, Koukouratos T, Oikonomou KA, Kostas A, Zampeli E, Papadopoulos V, Theodoropoulou A, Viazis N, Polymeros D, Michopoulos S, Bamias G, Kapsoritakis A, Karamanolis DG, Mantzaris GJ, Tzathas C, Koutroubakis IE. Karmiris K, et al. Among authors: michopoulos s. J Crohns Colitis. 2016 Apr;10(4):429-36. doi: 10.1093/ecco-jcc/jjv232. Epub 2015 Dec 30. J Crohns Colitis. 2016. PMID: 26721936 Free PMC article.
Systemic levels of human β-defensin 1 are elevated in patients with cirrhosis.
Kaltsa G, Bamias G, Siakavellas SI, Goukos D, Karagiannakis D, Zampeli E, Vlachogiannakos J, Michopoulos S, Vafiadi I, Daikos GL, Ladas SD. Kaltsa G, et al. Among authors: michopoulos s. Ann Gastroenterol. 2016 Jan-Mar;29(1):63-70. Ann Gastroenterol. 2016. PMID: 26751578 Free PMC article.
Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort.
Bamias G, Kokkotis G, Gizis M, Kapizioni C, Karmiris K, Koureta E, Kyriakos N, Leonidakis G, Makris K, Markopoulos P, Michalopoulos G, Michopoulos S, Papaconstantinou I, Polymeros D, Siakavellas SI, Triantafyllou K, Tsironi E, Tsoukali E, Tzouvala M, Viazis N, Xourafas V, Zacharopoulou E, Zampeli E, Zografos K, Papatheodoridis G, Mantzaris G. Bamias G, et al. Among authors: michopoulos s. Dig Dis Sci. 2022 Mar;67(3):1007-1017. doi: 10.1007/s10620-021-06907-5. Epub 2021 Mar 9. Dig Dis Sci. 2022. PMID: 33751325 Free PMC article.
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.
Bressler B, Yarur A, Silverberg MS, Bassel M, Bellaguarda E, Fourment C, Gatopoulou A, Karatzas P, Kopylov U, Michalopoulos G, Michopoulos S, Navaneethan U, Rubin DT, Siffledeen J, Singh A, Soufleris K, Stein D, Demuth D, Mantzaris GJ. Bressler B, et al. Among authors: michopoulos s. J Crohns Colitis. 2021 Oct 7;15(10):1694-1706. doi: 10.1093/ecco-jcc/jjab058. J Crohns Colitis. 2021. PMID: 33786600 Free PMC article.
Response to Anti-α4β7 Blockade in Patients With Ulcerative Colitis Is Associated With Distinct Mucosal Gene Expression Profiles at Baseline.
Gazouli M, Dovrolis N, Bourdakou MM, Gizis M, Kokkotis G, Kolios G, Michalopoulos G, Michopoulos S, Papaconstantinou I, Tzouvala M, Viazis N, Xourafas V, Zacharopoulou E, Zampeli E, Mantzaris G, Papatheodoridis G, Bamias G. Gazouli M, et al. Among authors: michopoulos s. Inflamm Bowel Dis. 2022 Jan 5;28(1):87-95. doi: 10.1093/ibd/izab117. Inflamm Bowel Dis. 2022. PMID: 34042157
77 results